PRAME and liposarcoma: In addition, PRAME expression in dedifferentiated liposarcomas has been associated with reduced programmed death ligand‐1 (PD‐L1) expression, a well‐known immune checkpoint ligand that regulates the activity of cytotoxic T lymphocytes through binding to its T cell inhibitory receptor PD‐1.25